Literature DB >> 14871532

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo.

Ian F Hermans1, Jonathan D Silk, Jianping Yang, Michael J Palmowski, Uzi Gileadi, Corinna McCarthy, Mariolina Salio, Franca Ronchese, Vincenzo Cerundolo.   

Abstract

Assessment of cell-mediated toxicity has traditionally been achieved by measuring the specific activity of enriched effector cell populations against antigen-loaded target cells labeled with radioactive isotopes in vitro. Fluorometric techniques are viewed as a promising alternative to the use of radioactive isotopes for these analyses. Direct assessment of cytotoxicity in vivo can be achieved by monitoring survival of injected fluorescent targets relative to a differentially labeled internal control population without specific antigen. We have developed this approach, incorporating the use of multiple target cell populations labeled with different dyes so that cytotoxicity can be assessed against titrated doses of a given antigen, or against a range of different antigens, simultaneously. We show that this assay, referred to as the VITAL assay, can be used to assess cytotoxic activity of CTL and iNKT cells in vivo and in vitro. CTL responses measured in vivo could be correlated with antigen doses used in immunization strategies, and also with the size of specific CTL populations enumerated in the blood with fluorescent MHC/peptide tetramers. The VITAL assay is, therefore, a sensitive technique allowing analysis of complex multi-epitope responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871532     DOI: 10.1016/j.jim.2003.10.017

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  79 in total

1.  Treatment of advanced leukemia in mice with mRNA engineered T cells.

Authors:  David M Barrett; Yangbing Zhao; Xiaojun Liu; Shuguang Jiang; Carmine Carpenito; Michael Kalos; Richard G Carroll; Carl H June; Stephan A Grupp
Journal:  Hum Gene Ther       Date:  2011-09-23       Impact factor: 5.695

2.  A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

Authors:  Benjamin J D Weist; Patrizia Wehler; Linda El Ahmad; Michael Schmueck-Henneresse; Jason M Millward; Mikalai Nienen; Avidan U Neumann; Petra Reinke; Nina Babel
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

3.  Tissue exit: a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza a virus-infected lung.

Authors:  Silke Jennrich; Michael H Lee; Rachel C Lynn; Kristofer Dewberry; Gudrun F Debes
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells.

Authors:  Jennifer L Matsuda; Qianjun Zhang; Rachel Ndonye; Stewart K Richardson; Amy R Howell; Laurent Gapin
Journal:  Blood       Date:  2005-12-15       Impact factor: 22.113

5.  Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.

Authors:  James N Kochenderfer; Steven A Feldman; Yangbing Zhao; Hui Xu; Mary A Black; Richard A Morgan; Wyndham H Wilson; Steven A Rosenberg
Journal:  J Immunother       Date:  2009-09       Impact factor: 4.456

6.  In Vivo Suppression of Heat Shock Protein (HSP)27 and HSP70 Accelerates DMBA-Induced Skin Carcinogenesis by Inducing Antigenic Unresponsiveness to the Initiating Carcinogenic Chemical.

Authors:  Nabiha Yusuf; Tahseen H Nasti; Israr Ahmad; Sanim Chowdhury; Hasan Mohiuddin; Hui Xu; Mohammad Athar; Laura Timares; Craig A Elmets
Journal:  J Immunol       Date:  2015-04-03       Impact factor: 5.422

7.  Estimating in vivo death rates of targets due to CD8 T-cell-mediated killing.

Authors:  Vitaly V Ganusov; Rob J De Boer
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Authors:  Shawn D Blackburn; Alison Crawford; Haina Shin; Antonio Polley; Gordon J Freeman; E John Wherry
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

9.  Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner.

Authors:  Talyn Chu; Aaron J Tyznik; Sarah Roepke; Amy M Berkley; Amanda Woodward-Davis; Laura Pattacini; Michael J Bevan; Dietmar Zehn; Martin Prlic
Journal:  Cell Rep       Date:  2013-03-21       Impact factor: 9.423

10.  Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo.

Authors:  Joshua S Woodworth; Ying Wu; Samuel M Behar
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.